Literature DB >> 9287389

Total joint arthroplasty and the immune response.

C A Toumbis1, J L Kronick, P H Wooley, S Nasser.   

Abstract

Total joint replacement arthroplasty has proved highly successful in the management of osteoarthritis and rheumatoid arthritis. The cause of aseptic loosening of prosthetic joint replacement components is unclear. Early experience with total joint arthroplasty was plagued by a number of problems that no longer exist as major impediments to long-term success. Improvement in the operating room environment and the use of prophylactic antibiotics have substantially reduced the high incidence of infection to less than 1%. Implant materials have long been considered biologically inert, but recent studies indicate that inflammatory reactions directed against the implanted materials may contribute to aseptic loosening. Currently, particulate debris from cement or polyethylene causing loosening of the prosthesis is the major problem in total joint arthroplasty. Significant data suggest a progression from a simple inflammatory reaction to complex immune responses against the biomaterials. The cellular responses to particles of polymethylmethacrylate, ultra-high-molecular-weight polyethylene, and alloys of cobalt-chromium and titanium have been assayed in vitro in patients with osteoarthritis, rheumatoid arthritis, and avascular necrosis who had total joint replacement. Elevated immunologic cell proliferation responses to both acrylic and cobalt chromium were observed in patients with aseptically loosened prostheses. These findings suggest that the development of a cellular response to particulate debris may be significant in the pathogenesis of aseptic loosening.

Entities:  

Mesh:

Year:  1997        PMID: 9287389     DOI: 10.1016/s0049-0172(97)80036-4

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  8 in total

1.  A hydrophobically-modified alginate gel system: utility in the repair of articular cartilage defects.

Authors:  Mohammad Kazem Ghahramanpoor; Sayed Alireza Hassani Najafabadi; Majid Abdouss; Fatemeh Bagheri; Mohamadreza Baghaban Eslaminejad
Journal:  J Mater Sci Mater Med       Date:  2011-07-21       Impact factor: 3.896

2.  [Nuclear medical imaging in case of painful knee arthroplasty].

Authors:  S Gratz; H Höffken; J W Kaiser; T M Behr; H Strosche; P Reize
Journal:  Radiologe       Date:  2009-01       Impact factor: 0.635

3.  The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure.

Authors:  Tao Zhang; Haiying Yu; Weiming Gong; Laibo Zhang; Tanghong Jia; Paul H Wooley; Shang-You Yang
Journal:  Biomaterials       Date:  2009-08-07       Impact factor: 12.479

4.  Spinal fusion-hardware construct: Basic concepts and imaging review.

Authors:  Mohamed Ragab Nouh
Journal:  World J Radiol       Date:  2012-05-28

Review 5.  Nuclear medicine and the failed joint replacement: Past, present, and future.

Authors:  Christopher J Palestro
Journal:  World J Radiol       Date:  2014-07-28

6.  Polyethylene wear particles induce TLR 2 upregulation in the synovial layer of mice.

Authors:  A C Paulus; J Frenzel; A Ficklscherer; B P Roßbach; C Melcher; V Jansson; S Utzschneider
Journal:  J Mater Sci Mater Med       Date:  2013-11-19       Impact factor: 3.896

7.  Regulation of Cortisol in Patients Undergoing Total Joint Arthoplasty.

Authors:  Rajan Khanna; Hannah Slovacek; Jeffrey Liles; Sandra Haddad; Pavel Poredos; Emily Bontekoe; Mateja Jezovnik; Debra Hoppensteadt; Jawed Fareed; William Hopkinson
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

8.  GSK-3β suppression upregulates Gli1 to alleviate osteogenesis inhibition in titanium nanoparticle-induced osteolysis.

Authors:  Qing Wang; Wei Zhang; Xiaole Peng; Yunxia Tao; Ye Gu; Wenming Li; Xiaolong Liang; Liangliang Wang; Zerui Wu; Tianhao Wang; Haifeng Zhang; Xin Liu; Yaozeng Xu; Yu Liu; Jun Zhou; Dechun Geng
Journal:  J Nanobiotechnology       Date:  2022-03-19       Impact factor: 9.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.